The spectrum of large granular lymphocyte leukemia and Felty's syndrome

Current Opinion in Hematology

Volumn 18, Issue 4, 2011, Pages 254-259

  Liu, Xin ^a   Loughran Jr , Thomas P ^a  

^a PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

autoimmune disease; Felty's syndrome; large granular lymphocyte leukemia

Indexed keywords

2 CHLOROXYADENOSINE; 2' DEOXYCOFORMYCINE; ALEMTUZUMAB; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DISEASE MODIFYING ANTIRHEUMATIC DRUG; FAS LIGAND; FLUDARABINE; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; METHOTREXATE; NUCLEOSIDE ANALOG; RANTES; RITUXIMAB; UNCLASSIFIED DRUG;

ANEMIA; ANTIBODY DETECTION; APOPTOSIS; ARTICLE; BOVINE LEUKEMIA VIRUS; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL FEATURE; CYTOTOXICITY; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; FELTY SYNDROME; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; JOINT DESTRUCTION; LARGE GRANULAR LYMPHOCYTE LEUKEMIA; LOW DRUG DOSE; NEUTROPENIA; PRIORITY JOURNAL; PURE RED CELL ANEMIA; RECURRENT INFECTION; RHEUMATOID ARTHRITIS; SPLENECTOMY; SPLENOMEGALY; SURVIVAL TIME; TREATMENT DURATION; TREATMENT INDICATION; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; WESTERN BLOTTING;

ARTHRITIS, RHEUMATOID; FELTY'S SYNDROME; HISTOCOMPATIBILITY TESTING; HLA-DR4 ANTIGEN; HUMANS; LEUKEMIA, LARGE GRANULAR LYMPHOCYTIC; NEUTROPENIA;

EID: 79958784146     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32834760fb     Document Type: Article

References (77)

1. Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist 2006; 11:263-273.
2. Lim MS, de Leval L, Quintanilla-Martinez L. Commentary on the 2008 WHO classification of mature T-and NK-cell neoplasms. J Hematop 2009; 2:75-76.
3. Loughran TP Jr, Kadin ME, Starkebaum G, et al. Leukemia of large granular lymphocytes: association with clonal chromosomal abnormalities and autoimmune neutropenia, thrombocytopenia, and hemolytic anemia. Ann Intern Med 1985; 102:169-175. (Pubitemid 15157163)
4. Wallis WJ, Loughran TP Jr, Kadin ME, et al. Polyarthritis and neutropenia associated with circulating large granular lymphocytes. Ann Intern Med 1985; 103:357-362. (Pubitemid 15236568)
5. Felty A. Chronic arthritis in the adult, associated with splenomegaly and leukopenia. Bull Johns Hopkins Hosp 1924; 35:16.
6. Burks EJ, Loughran TP Jr. Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndrome. Blood Rev 2006; 20:245-266. (Pubitemid 44209204)
7. Bowman SJ, Bhavnani M, Geddes GC, et al. Large granular lymphocyte expansions in patients with Felty's syndrome: analysis using anti-T cell receptor V beta-specific monoclonal antibodies. Clin Exp Immunol 1995; 101:18-24.
8. Loughran TP Jr, Starkebaum G, Kidd P, Neiman P. Clonal proliferation of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1988; 31:31-36. (Pubitemid 18078232)
9. Lanchbury JS, Jaeger EE, Sansom DM, et al. Strong primary selection for the Dw4 subtype of DR4 accounts for the HLA-DQw7 association with Felty's syndrome. Hum Immunol 1991; 32:56-64.
10. Bowman SJ, Sivakumaran M, Snowden N, et al. The large granular lymphocyte syndrome with rheumatoid arthritis. Immunogenetic evidence for a broader definition of Felty's syndrome. Arthritis Rheum 1994; 37:1326-1330. (Pubitemid 24320750)
11. Starkebaum G, Loughran TP Jr, Gaur LK, et al. Immunogenetic similarities between patients with Felty's syndrome and those with clonal expansions of large granular lymphocytes in rheumatoid arthritis. Arthritis Rheum 1997; 40:624-626. (Pubitemid 27157566)
12. Starkebaum G. Leukemia of large granular lymphocytes and rheumatoid arthritis. Am J Med 2000; 108:744-745. (Pubitemid 30621465)
13. Samanta A, Grant I, Nichol FE, et al. Large granular lymphocytosis associated with rheumatoid arthritis. Ann Rheum Dis 1988; 47:873-875.
14. Loughran TP Jr, Starkebaum G. Large granular lymphocyte leukemia. Report of 38 cases and review of the literature. Medicine (Baltimore) 1987; 66:397-405. (Pubitemid 18020235)
15. Lamy T, Loughran TPJr. How we treat LGL leukemia. Blood 2010;117:2754-2774.
16. Loughran TPJr. Clonal diseases of large granular lymphocytes. Blood 1993; 82:1-14. (Pubitemid 23188739)
17. Firestein GS. Evolving concepts of rheumatoid arthritis. Nature 2003; 423:356-361. (Pubitemid 40852711)
18. Kwong YL, Au WY, Leung AY, Tse EW. T-cell large granular lymphocyte leukemia: an Asian perspective. Ann Hematol 2010; 89:331-339.
19. Epling-Burnette PK, Loughran TPJr. Survival signals in leukemic large granular lymphocytes. Semin Hematol 2003; 40:213-220. (Pubitemid 36842599)
20. O'Keefe CL, Plasilova M, Wlodarski M, et al. Molecular analysis of TCR clonotypes in LGL: a clonal model for polyclonal responses. J Immunol 2004; 172:1960-1969. (Pubitemid 38116847)
21. Wlodarski MW, O'Keefe C, Howe EC, et al. Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia. Blood 2005; 106:2769-2780. (Pubitemid 41510753)
22. Rosenstein ED, Kramer N. Felty's and pseudo-Felty's syndromes. Semin Arthritis Rheum 1991; 21:129-142.
23. Goldberg J, Pinals RS. Felty syndrome. Semin Arthritis Rheum 1980; 10:52-65. (Pubitemid 11244783)
24. Rose MG, Berliner N. T-cell large granular lymphocyte leukemia and related disorders. Oncologist 2004; 9:247-258. (Pubitemid 38756874)
25. Mori KL, Furukawa H, Hayashi K, et al. Pure red cell aplasia associated with expansion of CD3\+ CD8\+ granular lymphocytes expressing cytotoxicity against HLA-E\+ cells. Br J Haematol 2003; 123:147-153. (Pubitemid 37222773)
26. Breedveld FC, Lafeber GJ, de Vries E, et al. Immune complexes and the pathogenesis of neutropenia in Felty's syndrome. Ann Rheum Dis 1986; 45:696-702. (Pubitemid 16038574)
27. Zhang R, Shah MV, Loughran TP Jr. The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders. Hematol Oncol 2010; 28:105-117.
28. Berliner N, Horwitz M, Loughran TPJr. Congenital and acquired neutropenia. Hematology Am Soc Hematol Educ Program 2004:63-79.
29. Morice WG, Kurtin PJ, Tefferi A, Hanson CA. Distinct bone marrow findings in T-cell granular lymphocytic leukemia revealed by paraffin section immunoperoxidase stains for CD8, TIA-1, and granzyme B. Blood 2002; 99:268-274.
30. Lamy T, Loughran TP Jr. Current concepts: large granular lymphocyte leukemia. Blood Rev 1999; 13:230-240. (Pubitemid 30157644)
31. Liu JH, Wei S, Lamy T, et al. Chronic neutropenia mediated by fas ligand. Blood 2000; 95:3219-3222. (Pubitemid 30321177)
32. Lamy T, Loughran TP Jr. Clinical features of large granular lymphocyte leukemia. Semin Hematol 2003; 40:185-195. (Pubitemid 36842596)
33. Osuji N, Matutes E, Catovsky D, et al. Histopathology of the spleen in T-cell large granular lymphocyte leukemia and T-cell prolymphocytic leukemia: a comparative review. Am J Surg Pathol 2005; 29:935-941. (Pubitemid 40885017)
34. van Krieken JH, Breedveld FC, te Velde J. The spleen in Felty's syndrome: a histological, morphometrical, and immunohistochemical study. Eur J Haematol 1988; 40:58-64. (Pubitemid 18096914)
35. Fishman D, Isenberg DA. Splenic involvement in rheumatic diseases. Semin Arthritis Rheum 1997; 27:141-155. (Pubitemid 28012045)
36. Bowman SJ, Hall MA, Panayi GS, Lanchbury JS. T cell receptor alpha-chain and beta-chain junctional region homology in clonal CD3\+, CD8\+ T lymphocyte expansions in Felty's syndrome. Arthritis Rheum 1997; 40:615-623.
37. Vallejo AN, Schirmer M, Weyand CM, Goronzy JJ. Clonality and longevity of CD4\+CD28null T cells are associated with defects in apoptotic pathways. J Immunol 2000; 165:6301-6307.
38. Schirmer M, Vallejo AN, Weyand CM, Goronzy JJ. Resistance to apoptosis and elevated expression of Bcl-2 in clonally expanded CD4\+CD28-T cells from rheumatoid arthritis patients. J Immunol 1998; 161:1018-1025. (Pubitemid 28323570)
39. Melenhorst JJ, Brummendorf TH, Kirby M, et al. CD8\+ T cells in large granular lymphocyte leukemia are not defective in activation-and replication-related apoptosis. Leuk Res 2001; 25:699-708. (Pubitemid 32496159)
40. Bigouret V, Hoffmann T, Arlettaz L, et al. Monoclonal T-cell expansions in asymptomatic individuals and in patients with large granular leukemia consist of cytotoxic effector T cells expressing the activating CD94:NKG2C/E and NKD2D killer cell receptors. Blood 2003; 101:3198-3204. (Pubitemid 36858015)
41. Namekawa T, Snyder MR, Yen JH, et al. Killer cell activating receptors function as costimulatory molecules on CD4\+CD28null T cells clonally expanded in rheumatoid arthritis. J Immunol 2000; 165:1138-1145. (Pubitemid 30484786)
42. Perzova R, Loughran TP Jr. Constitutive expression of Fas ligand in large granular lymphocyte leukaemia. Br J Haematol 1997; 97:123-126. (Pubitemid 27179573)
43. Oshimi K, Shinkai Y, Okumura K, et al. Perforin gene expression in granular lymphocyte proliferative disorders. Blood 1990; 75:704-708. (Pubitemid 20069212)
44. Gulan G, Ravlic-Gulan J, Strbo N, et al. Systemic and local expression of perforin in lymphocyte subsets in acute and chronic rheumatoid arthritis. J Rheumatol 2003; 30:660-670. (Pubitemid 36402756)
45. Kothapalli R, Nyland SB, Kusmartseva I, et al. Constitutive production of proinflammatory cytokines RANTES, MIP-1b and IL-18 characterizes LGL leukemia. Int J Oncol 2005; 26:529-535.
46. Lisignoli G, Toneguzzi S, Grassi F, et al. Different chemokines are expressed in human arthritic bone biopsies: IFN-gamma and IL-6 differently modulate IL-8, MCP-1 and RANTES production by arthritic obsteoblasts. Cytokine 2002; 20:231-238. (Pubitemid 37163476)
47. Lamy T, Liu JH, Landowski TH, et al. Dysregulation of CD95/CD95 ligandapoptotic pathway in CD3(\+) large granular lymphocyte leukemia. Blood 1998; 92:4771-4777. (Pubitemid 29005880)
48. Korb A, Pavenstadt H, Pap T. Cell death in rheumatoid arthritis. Apoptosis 2009; 14:447-454.
49. Fitzgerald JE, Ricalton NS, Meyer AC, et al. Analysis of clonal CD8\+ T cell expansions in normal individuals and patients with rheumatoid arthritis. J Immunol 1995; 154:3538-3547.
50. Wang EC, Lawson TM, Vedhara K, et al. CD8high\+(CD57\+) T cells in patients with rheumatoid arthritis. Arthritis Rheum 1997; 40:237-248. (Pubitemid 27114087)
51. Masuko-hongo K, Sekine T, Ueda S, et al. Long-term persistent accumulation of CD8\+ T cells in synovial fluid of rheumatoid arthritis. Ann Rheum Dis 1997; 56:613-621. (Pubitemid 27444646)
52. Kang YM, Zhang X, Wagner UG, et al. CD8 T cells are required for the formation of ectopic germinal centers in rheumatoid synovitis. J Exp Med 2002; 195:1325-1336. (Pubitemid 34564334)
53. Tan LC, Mowat AG, Fazou C, et al. Specificity of T cells in synovial fluid: high frequencies of CD8(\+) T cells that are specific for certain viral epitopes. Arthritis Res 2000; 2:154-164. (Pubitemid 32223720)
54. Loughran TP Jr, Hadlock KG, Perzova R, et al. Epitope mapping of HTLV envelope seroreactivity in LGL leukaemia. Br J Haematol 1998; 101:318-324. (Pubitemid 28261120)
55. Loughran TP Jr, Coyle T, Sherman MP, et al. Detection of human T-cell leukemia/lymphoma virus, type II, in a patient with large granular lymphocyte leukemia. Blood 1992; 80:1116-1119.
56. Pandolfi F, Shriver K, Scarselli E, et al. HTLV-I antibodies and lymphoproliferative disease of granular lymphocytes. Lancet 1987; 2:1527. (Pubitemid 18013778)
57. Starkebaum G, Loughran TP Jr, Kalyanaraman VS, et al. Serum reactivity to human T-cell leukaemia/lymphoma virus type I proteins in patients with large granular lymphocytic leukaemia. Lancet 1987; 1:596-599.
58. Levitt LJ, Reyes GR, Moonka DK, et al. Human T cell leukemia virus-Iassociated T-suppressor cell inhibition of erythropoiesis in a patient with pure red cell aplasia and chronic T gamma-lymphoproliferative disease. J Clin Invest 1988; 81:538-548. (Pubitemid 18075250)
59. Loughran TP Jr, Sherman MP, Ruscetti FW, et al. Prototypical HTLV-I/II infection is rare in LGL leukemia. Leuk Res 1994; 18:423-429. (Pubitemid 24169824)
60. Starkebaum G, Shasteen NM, Fleming-Jones RM, et al. Sera of patients with rheumatoid arthritis contain antibodies to recombinant human T-lymphotrophic virus type I/II envelope glycoprotein p21. Clin Immunol Immunopathol 1996; 79:182-188. (Pubitemid 26150341)
61. Sokol L, Agrawal D, Loughran TP Jr. Characterization of HTLV envelope seroreactivity in large granular lymphocyte leukemia. Leuk Res 2005; 29:381-387. (Pubitemid 40255811)
62. Loughran TP Jr, Kidd PG, Starkebaum G. Treatment of large granular lymphocyte leukemia with oral low-dose methotrexate. Blood 1994; 84: 2164-2170. (Pubitemid 24296373)
63. Battiwalla M, Melenhorst J, Saunthararajah Y, et al. HLA-DR4 predicts haematological response to cyclosporine in T-large granular lymphocyte lymphoproliferative disorders. Br J Haematol 2003; 123:449-453. (Pubitemid 37363485)
64. Matrai Z, Lelkes G, Milosevits J, et al. T-cell large granular lymphocytic leukemia associated with pure red cell aplasia, successfully treated with cyclophosphamide. Orv Hetil 1997; 138:2075-2080.
65. Balint GP, Balint PV. Felty's syndrome. Best Pract Res Clin Rheumatol 2004; 18:631-645. (Pubitemid 39555467)
66. Tan N, Grisanti MW, Grisanti JM. Oral methotrexate in the treatment of Felty's syndrome. J Rheumatol 1993; 20:599-601. (Pubitemid 23102510)
67. Wassenberg S, Herborn G, Rau R. Methotrexate treatment in Felty's syndrome. Br J Rheumatol 1998; 37:908-911.
68. Sood R, Stewart CC, Aplan PD, et al. Neutropenia associated with T-cell large granular lymphocyte leukemia: long-term response to cyclosporine therapy despite persistence of abnormal cells. Blood 1998; 91:3372-3378. (Pubitemid 28193889)
69. Lamy T, LePrise PY, Amiot L, et al. Response to granulocyte-macrophage colony-stimulating factor (GM-CSF) but not to G-CSF in a case of agranulocytosis associated with large granular lymphocyte (LGL) leukemia. Blood 1995; 85:3352-3353.
70. Weide R, Heymanns J, Koppler H, et al. Successful treatment of neutropenia in T-LGL leukemia (T gamma-lymphocytosis) with granulocyte colony-stimulating factor. Ann Hematol 1994; 69:117-119. (Pubitemid 24284967)
71. Sternberg A, Eagleton H, Pillai N, et al. Neutropenia and anaemia associated with T-cell large granular lymphocyte leukaemia responds to fludarabine with minimal toxicity. Br J Haematol 2003; 120:699-701. (Pubitemid 36255874)
72. Osuji N, Del Giudice I, Matutes E, et al. CD52 expression in T-cell large granular lymphocyte leukemia: implications for treatment with alemtuzumab. Leuk Lymphoma 2005; 46:723-727. (Pubitemid 40775221)
73. Lekharaju V, Chattopadhyay C. Efficacy of rituximab in Felty's syndrome. Ann Rheum Dis 2008; 67:1352.
74. Weinreb N, Rabinowitz A, Dellaripa PF. Beneficial response to rituximab in refractory Felty syndrome. J Clin Rheumatol 2006; 12:48. (Pubitemid 44384015)
75. Chandra PA, Margulis Y, Schiff C. Rituximab is useful in the treatment of Felty's syndrome. Am J Ther 2008; 15:321-322.
76. Subbiah V, Viny AD, Rosenblatt S, et al. Outcomes of splenectomy in T-cell large granular lymphocyte leukemia with splenomegaly and cytopenia. Exp Hematol 2008; 36:1078-1083.
77. Gentile TC, Loughran TP Jr. Resolution of autoimmune hemolytic anemia following splenectomy in CD3\+ large granular lymphocyte leukemia. Leuk Lymphoma 1996; 23:405-408.